![]() |
市場調查報告書
商品編碼
2049349
心血管資訊系統市場規模、佔有率、趨勢和預測:按類型、組件、運作模式、最終用戶、應用和地區分類,2026-2034年Cardiovascular Information System Market Size, Share, Trends and Forecast by Type, Component, Mode of Operation, End-User, Application, and Region, 2026-2034 |
||||||
2025年全球心血管資訊系統市場規模為13.026億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到24.439億美元,2026年至2034年的複合年成長率(CAGR)為7.02%。目前,北美市場佔據主導地位,預計到2025年將佔據超過33.2%的市場。該市場正經歷顯著成長,主要受心臟病發病率上升、診斷技術進步以及對高效醫療解決方案需求不斷成長的推動。
機器學習和人工智慧 (AI) 與心血管資訊系統 (CIS) 的日益融合,正在推動心臟疾病診斷和患者管理的進步。 AI 驅動的 CIS 平台增強了即時數據分析能力,實現了風險評估的自動化,並改善了早期疾病檢測的決策。此外,基於雲端的 CIS 解決方案的日益普及,簡化了跨多個醫療機構的數據訪問,實現了無縫互通性和遠端患者監護。心血管疾病 (CVD) 盛行率的上升和人口老化加速了對預測分析和個人化治療策略的需求。此外,基於價值的醫療模式的推進,也促使醫療服務提供者投資於能夠提高臨床效率和改善患者預後的 CIS 技術。在醫療保健領域網路安全威脅日益加劇的背景下,加強資料安全和合規措施也成為 CIS 開發的關鍵重點。
此外,包括FDA核准人工智慧診斷工具在內的監管支援正在推動市場成長。 Cardio Diagnostics於2025年2月進行的擴張鞏固了美國食品藥物管理局,凸顯了對精準心血管醫學日益成長的需求。 Epi+Gen CHD和PrecisionCHD在醫療機構的部署,強調了在心臟病風險評估和管理中,基於人工智慧的表觀遺傳學診斷技術的轉變。由於冠狀動脈疾病仍是美國的主要死因,此次擴張強化了CIS平台在預防醫學中的作用,從而能夠實現更積極主動和個人化的治療方案。此外,包括密西根州、伊利諾伊州、德克薩斯州、佛羅裡達州、加利福尼亞州和康乃狄克州在內的多個地區的醫療機構正在利用這些人工智慧工具來改善患者的治療效果。在CIS解決方案中採用基因和表觀遺傳學檢測,顯示精準醫學日受到重視,並與以數據驅動、以患者為中心的醫療模式的行業趨勢相符。
心血管疾病(CVD)病例的增加和數位化進程的推進
醫療保健產業的擴張和多種心血管疾病發生率的上升是推動市場成長的主要因素。報告顯示,2025年至2050年間,心血管疾病的發生率預計將增加90%,到2050年,心血管相關死亡人數預計將達到3,560萬,較2025年的2,050萬大幅增加。在全球範圍內,由於人口老化和久坐生活方式的盛行,心臟衰竭、缺血性心臟疾病(IHD)和心律不整患者的數量正在激增。世界衛生組織(WHO)預測,到2050年,約80%的老年人將居住在中低收入國家。這凸顯了迫切需要擴充性的、數據驅動的醫療保健解決方案來應對心血管疾病等與老齡化相關的疾病。此外,數位化進步和醫療資訊科技(IT)的發展也在推動市場成長。醫療機構正在部署可遠端存取醫療資料和影像的系統,進一步提升診斷中心的效率和互通性。推動市場成長的另一個因素是零佔用空間系統的普及率逐漸提高。 CVIS 具備網路為基礎的資料傳輸功能,不僅易於部署,還能有效檢查壓縮資料集,無需額外的硬碟來儲存軟體。此外,對數據驅動型技術的需求不斷成長、技術進步以及積極的研發活動等其他因素也預計將推動市場發展。
先進的人工智慧技術在循環系統醫學的應用
人工智慧 (AI) 在循環系統的作用日益增強,推動了心血管資訊系統 (CIS) 的普及應用。 AI 工具正在改善風險評估、早期檢測和臨床決策。隨著心血管疾病病例的增加,醫療專業人員正致力於利用預測分析來改善患者預後。 AI 的整合能夠減少診斷錯誤、加速數據分析並簡化循環系統的工作流程。例如,2025 年 2 月,Heart Eye 公司發布了 Dr. Noon CVD,這是一款 AI 驅動的視網膜成像系統,其心血管風險評估的準確性可與心臟電腦斷層掃描相媲美。這種非侵入性解決方案透過加速篩檢、改善就診途徑和支持早期診斷來增強 CIS 的功能。 AI 驅動的預測模型的擴展正在透過提高效率、降低成本和支持個人化治療策略來推動 CIS 的普及應用。隨著醫院將自動化和數位轉型列為優先事項,AI 驅動的循環系統解決方案正變得至關重要。
加強心電圖(ECG)與診斷影像的互通性。
影像和心電圖平台之間無縫的資料交換和互通性是心血管資訊系統市場的關鍵促進因素。醫院和診所需要整合解決方案,以實現診斷工具、電子健康記錄(EHR) 和循環系統之間高效的資料流。增強互通性有助於提升決策水準、減少重複工作並簡化循環系統醫療保健中的病患管理。順應這一趨勢,飛利浦於 2024 年 6 月在歐洲、中東和非洲地區 (EMEA) 推出了“心臟工作站”,旨在改進心電圖數據分析和臨床工作流程。這項創新解決方案透過確保即時數據存取和風險評估支援來增強互通性,從而加速循環系統介入治療。隨著對先進影像和心電圖系統需求的不斷成長,供應商正致力於開發能夠提高連接性和效率的互通性解決方案。跨循環系統平台的標準化數據整合使心血管資訊系統 (CIS) 的部署更加有效,從而提高協作效率和臨床準確性。
The global cardiovascular information system market size was valued at USD 1,302.6 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,443.9 Million by 2034, exhibiting a CAGR of 7.02% during 2026-2034. North America currently dominates the market, holding a significant market share of over 33.2% in 2025. The market is experiencing significant growth, driven by the rising incidence of heart diseases, advancements in diagnostic technologies, and increasing demand for efficient healthcare solutions.
The increasing integration of machine learning and artificial intelligence into cardiovascular information systems is driving advancements in cardiology diagnostics and patient management. AI-powered CIS platforms enhance real-time data analysis, automate risk assessment, and improve decision-making for early disease detection. Additionally, the growing adoption of cloud-based CIS solutions is streamlining data accessibility across multiple healthcare facilities, enabling seamless interoperability and remote patient monitoring. The rising prevalence of cardiovascular diseases (CVDs), coupled with an aging population, is accelerating demand for predictive analytics and personalized treatment strategies. Furthermore, the push for value-based care models is prompting healthcare providers to invest in CIS technologies that improve clinical efficiency and patient outcomes. As cybersecurity threats in healthcare rise, enhanced data security and compliance measures are also becoming a key focus in CIS development.
Moreover, regulatory support, including the U.S. Food and Drug Administration approvals for AI-driven diagnostic tools, is fostering market growth. Cardio Diagnostics' expansion in February 2025 reinforces the U.S. Cardiovascular Information System sector, highlighting the increasing demand for precision cardiovascular medicine. The integration of Epi+Gen CHD and PrecisionCHD into provider organizations underscores the shift toward AI-driven, epigenetic-based diagnostics for heart disease risk assessment and management. As coronary heart disease remains the leading cause of death in the U.S., this expansion strengthens the role of CIS platforms in preventive healthcare, enabling more proactive and personalized treatment approaches. Additionally, healthcare providers in multiple regions, including Michigan, Illinois, Texas, Florida, California, and Connecticut, are leveraging these AI-powered tools to enhance patient outcomes. The adoption of genetic and epigenetic testing in CIS solutions signifies a growing emphasis on precision medicine, aligning with the industry's push toward data-driven, patient-centric care models.
Rising CVD Cases and Digital Adoption
The increasing healthcare sector, coupled with the incidence of numerous cardiovascular diseases, is one of the primary drivers of market growth. As per the reports, from 2025 to 2050, cardiovascular disease incidence is estimated to grow by 90%, and in 2050, 35.6 Million cardiovascular-related deaths are anticipated, which is a surprising increase from 20.5 Million in 2025. Due to the increase in the geriatric population and sedentary lifestyle patterns, the number of patients with cardiac failures, ischemic heart disease (IHD), and arrhythmia is drastically increasing globally. As per the World Health Organization (WHO), in 2050, almost 80% of elderly individuals will be residing in low- and middle-income nations, which is the reason that scalable, data-based healthcare solutions to deal with age-related conditions, such as cardiovascular diseases, are the need of the hour. In addition, the developing trend of digitization and developments in the healthcare information technology (IT) segment are also boosting the market growth. The healthcare organizations are adopting the system to access medical data and images remotely, thus further improving the diagnostic centers' efficiency and interoperability. Also, the gradually improving adoption rate of zero-footprint systems is playing another stimulating growth factor role. The CVIS dispenses with the requirement for extra hard drives to hold the software as it has the capability of data transfer via the web and offers the ease of delivery, in addition to the effective examination of compressed data sets. Several other factors, such as the growing need for data-driven technologies, advancements in technology and heavy research and development (R&D) efforts, are expected to push the market ahead.
Advanced AI Integration in Cardiology
The growing role of artificial intelligence in cardiology is driving the adoption of Cardiovascular Information Systems (CIS). AI-powered tools are enhancing risk assessment, early detection, and clinical decision-making. With increasing cardiovascular cases, healthcare providers are focusing on predictive analytics to improve patient outcomes. The integration of AI reduces diagnostic errors, accelerates data analysis, and streamlines workflows in cardiology. For instance, in February 2025, Heart Eye introduced Dr.Noon CVD, an AI-powered retinal imaging system that enables cardiovascular risk assessment with accuracy comparable to heart CT scans. This noninvasive solution enhances CIS by providing faster screenings, improving accessibility, and supporting early diagnosis. The expansion of AI-driven predictive models strengthens CIS adoption by improving efficiency, reducing costs, and supporting personalized treatment strategies. As hospitals prioritize automation and digital transformation, AI-powered cardiology solutions are becoming essential.
Enhanced ECG and Imaging Interoperability
Seamless data exchange and interoperability across imaging and ECG platforms are key drivers of the Cardiovascular Information System market. Hospitals and clinics need integrated solutions that enable efficient data flow between diagnostic tools, electronic health records (EHRs), and cardiology workstations. Improved interoperability enhances decision-making, reduces redundancies, and streamlines patient management in cardiovascular care. Aligned with this trends, in June 2024, Philips launched the Cardiac Workstation in EMEA, improving ECG data analysis and clinical workflows. This innovation enhances interoperability by ensuring real-time data access and risk assessment support, accelerating cardiology interventions. With the growing demand for advanced imaging and ECG systems, vendors are focusing on interoperable solutions to improve connectivity and efficiency. Standardized data integration across cardiology platforms is making CIS adoption more effective, improving collaboration and clinical accuracy.
Cardiovascular Information System (CVIS) stands as the largest segment by type, driving market expansion. The increasing demand for integrated data solutions in cardiology is a key factor fueling its dominance. CVIS streamlines workflow, enhances diagnostic accuracy, and improves patient management by centralizing imaging, ECG data, and clinical records. Hospitals and healthcare providers are prioritizing digital transformation, accelerating CVIS adoption. Advancements in AI-driven analytics, interoperability, and cloud-based platforms further strengthen its market position. Ongoing research and regulatory compliance efforts continue to enhance CVIS efficiency and scalability, ensuring sustained growth.
In 2025, software led the market by component with 32.6% of the market share. The rising demand for integrated data management, real-time diagnostics, and cloud-based solutions is driving this segment's growth. CVIS software enhances workflow automation, imaging interoperability, and clinical decision-making, improving cardiology care efficiency. Hospitals and diagnostic centers are increasingly adopting AI-powered analytics, boosting demand for advanced software solutions. The shift toward cloud-based, zero-footprint systems ensures seamless data access and regulatory compliance. Continuous R&D investments in AI-driven diagnostics and predictive analytics are further strengthening software's dominance, positioning it as the key growth driver in the CVIS market.
In 2025, web-based stand as the largest mode of operation holding around 74.8% of the market. The increasing demand for cloud-based platforms that enable remote access, seamless data integration, and real-time collaboration is driving adoption. Web-based CVIS enhances interoperability between hospitals, imaging centers, and cardiology departments, improving efficiency and patient outcomes. The shift toward digitization in healthcare, combined with growing investments in telecardiology, is reinforcing this trend. Hospitals and clinics are prioritizing web-based solutions due to their scalability, cost-effectiveness, and ability to support AI-driven analytics. Additionally, reduced infrastructure requirements and zero-footprint technology eliminate the need for extensive hardware installations. Rising cardiovascular disease cases and the need for instant, data-driven decision-making further fuel adoption. As regulatory bodies emphasize data security and interoperability, web-based CVIS remains the preferred choice, ensuring continuous market expansion.
In 2025, hospitals and clinics led the cardiovascular information system market, holding the largest share by end-user. The increasing prevalence of cardiovascular diseases (CVDs), coupled with rising patient admissions for cardiac care, is driving segment growth. Hospitals and specialized cardiac centers are rapidly adopting CVIS to enhance workflow efficiency, streamline diagnostics, and improve patient outcomes. These systems enable seamless integration of imaging, ECG data, and electronic health records (EHRs), ensuring faster and more accurate clinical decision-making. The demand for data-driven cardiac care is fueling investments in advanced CVIS solutions that support real-time monitoring and predictive analytics. Additionally, regulatory compliance and the shift toward value-based healthcare models are pushing hospitals to adopt interoperable systems, reinforcing their dominance in the CVIS market. Expanding telehealth services further accelerates this segment's growth.
In 2025, catheterization accounted for the largest market share of 20.7% . The increasing reliance on catheterization procedures for diagnosing and treating cardiovascular diseases is a key factor driving this segment. CVIS enhances workflow efficiency by integrating real-time imaging, hemodynamic monitoring, and patient data management, making it essential for catheterization labs. The growing prevalence of ischemic heart disease, arrhythmias, and structural heart conditions is fueling demand for advanced digital solutions that support precision diagnostics and intervention. Hospitals and specialized cardiology centers are adopting CVIS to streamline data analysis, improve decision-making, and enhance patient care. Regulatory mandates for standardized data integration and real-time analytics further boost adoption. Continuous advancements in imaging technology and AI-driven diagnostics are reinforcing CVIS adoption in catheterization, ensuring sustained market growth.
In 2025, the North America region dominated the cardiovascular information system market, accounting for the largest share over 33.2% . The region's leadership is driven by advanced healthcare infrastructure, strong digital adoption, and high cardiovascular disease (CVD) prevalence. Hospitals and cardiology centers are increasingly adopting CVIS to streamline patient management, enhance diagnostics, and improve clinical outcomes. The widespread integration of AI, cloud-based solutions, and electronic health records (EHRs) is further accelerating CVIS adoption. The presence of major healthcare IT providers and ongoing investments in data-driven cardiology solutions reinforce market growth. Additionally, regulatory frameworks promoting interoperability and patient-centric care are pushing healthcare facilities toward CVIS implementation. With rising demand for real-time data analytics and predictive healthcare models, North America continues to lead in CVIS adoption, driving innovation and efficiency in cardiology care.
UNITED STATES CARDIOVASCULAR INFORMATION SYSTEM MARKET ANALYSIS
In 2025, United States accounted for 88.60% of the market share in North America. The United States cardiovascular information system market is experiencing robust growth, driven by the increasing prevalence of cardiovascular diseases (CVDs) and the rising demand for streamlined healthcare data management solutions. According to the American Heart Association, cardiovascular disease claims more than 850,000 lives in the U.S. each year, highlighting the urgent need for advanced healthcare technologies to improve patient outcomes. The growing adoption of electronic health records (EHR) and the need for integrated platforms to manage patient information, diagnostic images, and treatment plans are key factors propelling market expansion. Advanced cardiovascular information systems offer real-time access to patient data, enabling healthcare providers to improve clinical decision-making and operational efficiency. The integration of cloud-based solutions, artificial intelligence (AI), and data analytics tools further enhances diagnostic accuracy and patient outcomes. Additionally, favorable government initiatives promoting healthcare digitization and interoperability are supporting the market growth. With the increasing shift toward value-based care models and rising investments in healthcare IT infrastructure, the United States cardiovascular information system market is poised for consistent expansion in the coming years.
EUROPE CARDIOVASCULAR INFORMATION SYSTEM MARKET ANALYSIS
The Europe cardiovascular information system market is witnessing steady growth, driven by rising healthcare digitization and the increasing burden of cardiovascular diseases (CVDs) across the region. According to the World Health Organization, CVDs are the leading cause of disability and premature death in the European Region, accounting for over 42.5% of all deaths annually, which translates to approximately 10,000 deaths per day. This alarming prevalence is pushing healthcare providers to adopt advanced data management solutions to improve patient care and early diagnosis. The demand for centralized cardiovascular information systems that enhance workflow efficiency, diagnostic precision, and data integration is driving adoption across hospitals, diagnostic centers, and specialty clinics. Technological advancements such as cloud-based platforms, remote patient monitoring, and AI-powered data analytics are reshaping the market landscape. Additionally, the widespread implementation of electronic health records (EHR) and adherence to GDPR are accelerating the deployment of these systems. Government initiatives and investments in smart healthcare infrastructure are creating lucrative opportunities for cardiovascular information system providers, making Europe a key market for future growth.
ASIA PACIFIC CARDIOVASCULAR INFORMATION SYSTEM MARKET ANALYSIS
The Asia Pacific cardiovascular information system market is expanding rapidly, fueled by increasing healthcare infrastructure development, rising healthcare expenditures, and the growing incidence of cardiovascular diseases. The adoption of healthcare IT solutions to improve clinical workflows and enhance patient care is significantly contributing to market growth. Healthcare providers in the region are leveraging cloud-based cardiovascular information systems to streamline patient data management, diagnostic imaging, and treatment planning. The rising awareness about digital healthcare solutions and increasing government investments in healthcare digitization projects are supporting market expansion. According to the India Brand Equity Foundation, the health-tech sector is set for significant expansion, with hiring projected to rise by 15-20% in 2024, reflecting the increasing demand for innovative healthcare solutions and the integration of technology in medical services. Moreover, the penetration of telemedicine platforms, AI-driven diagnostics, and mobile health applications is further boosting the adoption of cardiovascular information systems across the region, creating new growth opportunities for market players.
LATIN AMERICA CARDIOVASCULAR INFORMATION SYSTEM MARKET ANALYSIS
The Latin America cardiovascular information system market is growing due to the rise in cardiovascular diseases and the adoption of healthcare IT solutions. The demand for centralized data management systems is driving market expansion. Healthcare providers are integrating cloud-based systems for remote data access, patient monitoring, and collaborative decision-making. Government initiatives and customized solutions are creating new growth opportunities. Moreover, the rising aging population is anticipated to further drive the demand for cardiovascular information systems, as elderly individuals are more prone to developing cardiovascular diseases. According to reports, approximately 37.8% of Brazil's population will be aged 60 and over by 2070, highlighting the need for advanced healthcare solutions to support the region's growing geriatric population.
MIDDLE EAST AND AFRICA CARDIOVASCULAR INFORMATION SYSTEM MARKET ANALYSIS
The Middle East and Africa cardiovascular information system market is expanding due to healthcare modernization and digital transformation. The increasing burden of cardiovascular diseases and demand for efficient data management solutions are driving the adoption of these systems, which streamline patient data storage, diagnostic imaging, and treatment planning, and improve clinical decision-making. Additionally, rising government investments in healthcare IT infrastructure and strategic collaborations between public and private sectors are boosting the adoption of cardiovascular information systems across the region. For instance, the International Trade Administration states that under Vision 2030, the Saudi Arabian Government plans to invest over USD 65 Billion to develop the country's healthcare infrastructure, and reorganize, and privatize health services and insurance.
Technological advancements, data integration, and rising demand for efficient healthcare management are shaping the cardiovascular information system market. Expanding applications in hospitals, diagnostic centers, and specialty clinics, along with regulatory compliance and interoperability improvements, are driving market growth. Increasing investments in AI-driven analytics, cloud-based solutions, and workflow optimization are fostering innovation. Regional expansions, research initiatives, and evolving healthcare IT standards are intensifying competition, promoting cost-effective and high-performance solutions across various end-use settings.